An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome von Kellow, J, Lee, O Y, Chang, F Y, Thongsawat, S, Mazlam, M Z, Yuen, H, Gwee, K A, Bak, Y T, Jones, J, Wagner, A

Volltext

Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease von Mazlam, M Z, Hodgson, H J

Volltext

Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease von Mazlam, M Z, Hodgson, H J

Volltext

cagA gene variants in Malaysian Helicobacter pylori strains isolated from patients of different ethnic groups von Ramelah, Mohamed, Aminuddin, Ahmad, Alfizah, Hanafiah, Isa, Mohd Rose, Jasmi, Ali Yaakob, Tan, Huck Joo, Rahman, A. Jamal A., Rizal, Abdul Manap, Mazlam, M. Zawawi

Volltext

Why measure C reactive protein? von Mazlam, M Z, Hodgson, H J

Volltext

Optimal treatment for duodenal ulcer disease: A cost-decision analysis in Malaysian patients von Goh, Kl, Cutler, A, Chua, Abs, Ding, Rph, Kandasami, P, Mazlam, Mz, Raj, Sm

Volltext

Assessment of drug therapy in inflammatory bowel disease von HODGSON, H. J. F, MAZLAM, M. Z

Volltext

The optimal treatment for duodenal ulcer disease in Malaysian patients von Goh, KL, Cutler, AF, Chua, ABS, Ding, RPH, Kandasami, P, Mazlam, MZ, Raj, SM

Volltext

Campylobacter pylori, non-ulcer dyspepsia, and race in Malaysia von Nafeeza, M I, Shahimi, M M, Kudva, M V, Mazlam, M Z, Isa, M R

Volltext